HCV dsRNA-activated macrophages inhibit HCV replication in hepatocytes

Hepatitis Monthly

Volumn 15, Issue 8, 2015, Pages

  Wang, Yizhong ^a   Li, Jieliang ^b   Wang, Xu ^b   Zhou, Yu ^b   Zhang, Ting ^a   Ho, Wenzhe ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis C Virus; Interferon; Macrophages; Toll Like receptor 3

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DOUBLE STRANDED RNA; INTERFERON REGULATORY FACTOR 7; MESSENGER RNA; MYXOVIRUS RESISTANCE PROTEIN A; TOLL LIKE RECEPTOR 3; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIVER CELL; MACROPHAGE FUNCTION; MONOCYTE; NORMAL HUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; WESTERN BLOTTING;

EID: 84990310435     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.29282     Document Type: Article

References (38)

1. Alter MJ. Prevention of spread of hepatitis C. Hepatology. 2002;36(5 Suppl 1):S93-8.
2. Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signal­ing. Ann N Y Acad Sci. 2008;1143:1-20.
3. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006;7(2):131-7.
4. Kumar A, Zhang J, Yu FS. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells. Immunology. 2006;117(1):11-21.
5. West J, Damania B. Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Vi­rol. 2008;82(11):5440-9.
6. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like re­ceptor 3. Nature. 2001;413(6857):732-8.
7. Wang N, Liang Y, Devaraj S, Wang J, Lemon SM, Li K. Toll-like recep­tor 3 mediates establishment of an antiviral state against hepati­tis C virus in hepatoma cells. J Virol. 2009;83(19):9824-34.
8. Janeway CAJ, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216.
9. Li J, Ye L, Wang X, Hu S, Ho W. Induction of interferon-gamma contributes to Toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes. J Neurosci Res. 2012;90(2):399-406.
10. Zhou Y, Wang X, Liu M, Hu Q, Song L, Ye L, et al. A critical func­tion of toll-like receptor-3 in the induction of anti-human im­munodeficiency virus activities in macrophages. Immunology. 2010;131(1):40-9.
11. Battaglia AM, Hagmeyer KO. Combination therapy with inter­feron and ribavirin in the treatment of chronic hepatitis C infec­tion. Ann Pharmacother. 2000;34(4):487-94.
12. Gale MJ, Foy EM. Evasion of intracellular host defence by hepati­tis C virus. Nature. 2005;436(7053):939-45.
13. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005;102(8):2992-7.
14. Foy E, Li K, Sumpter RJ, Loo YM, Johnson CL, Wang C, et al. Con­trol of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A. 2005;102(8):2986-91.
15. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A. 2005;102(49):17717-22.
16. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology. 2006;43(2 Suppl 1):S54-62.
17. Khakoo SI, Soni PN, Savage K, Brown D, Dhillon AP, Poulter LW, et al. Lymphocyte and macrophage phenotypes in chronic hepa­titis C infection. Correlation with disease activity. Am J Pathol. 1997;150(3):963-70.
18. Heydtmann M. Macrophages in hepatitis B and hepatitis C virus infections. J Virol. 2009;83(7):2796-802.
19. Hassan NF, Campbell DE, Douglas SD. Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods. 1986;95(2):273-6.
20. Li K, Li NL, Wei D, Pfeffer SR, Fan M, Pfeffer LM. Activation of che­mokine and inflammatory cytokine response in hepatitis C vi­rus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates. Hepatol­ogy. 2012;55(3):666-75.
21. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A. 2005;102(26):9294-9.
22. Yang JH, Lai JP, Douglas SD, Metzger D, Zhu XH, Ho WZ. Real-time RT-PCR for quantitation of hepatitis C virus RNA. J Virol Methods. 2002;102(1-2):119-28.
23. Katze MG, He Y, Gale MJ. Viruses and interferon: a fight for su­premacy. Nat Rev Immunol. 2002;2(9):675-87.
24. Tuplin A, Wood J, Evans DJ, Patel AH, Simmonds P. Thermody­namic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA. 2002;8(6):824-41.
25. Liu X, He N, Fu Z, Duan S, Gao M, Zhang ZF. Plasma Hepatitis C Vi­rus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province,China. Hepat Mon. 2012;12(7):453-9.
26. Zhang S, Kodys K, Li K, Szabo G. Human type 2 myeloid den­dritic cells produce interferon-lambda and amplify interferon-alpha in response to hepatitis C virus infection. Gastroenterology. 2013;144(2):414-425 e7.
27. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Im­munol. 2005;17(1):1-14.
28. Argentini C, Genovese D, Dettori S, Rapicetta M. HCV genetic vari­ability: from quasispecies evolution to genotype classification. Future Microbiol. 2009;4(3):359-73.
29. Radkowski M, Bednarska A, Horban A, Stanczak J, Wilkinson J, Adair DM, et al. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol. 2004;85(Pt 1):47-59.
30. Revie D, Salahuddin SZ. Role of macrophages and mono­cytes in hepatitis C virus infections. World J Gastroenterol. 2014;20(11):2777-84.
31. Fletcher NF, Sutaria R, Jo J, Barnes A, Blahova M, Meredith LW, et al. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology. 2014;59(4):1320-30.
32. Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B, Papic N, et al. IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 2013;9(4):e1003330.
33. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology. 2003;38(5):1188-98.
34. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, et al. Hepatitis C core and nonstructural 3 proteins trig­ger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology. 2004;127(5):1513-24.
35. Chang S, Dolganiuc A, Szabo G. Toll-like receptors 1 and 6 are in­volved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol. 2007;82(3):479-87.
36. Chattergoon MA, Latanich R, Quinn J, Winter ME, Buckheit R, Blankson JN, et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like re­ceptors without induction of type 1 interferon. PLoS Pathog. 2014;10(5):e1004082.
37. Alavian SM, Ande SR, Coombs KM, Yeganeh B, Davoodpour P, Hashemi M, et al. Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development. J Viral Hepat. 2011;18(12):821-30.
38. Khattab MA, Eslam M, Alavian SM. Hepatitis C virus as a multi­faceted disease: a simple and updated approach for extrahe­patic manifestations of hepatitis C virus infection. Hepat Mon. 2010;10(4):258-69.